Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

Clinical trial NCT01685827 · COMPLETED

Trial details

NCT number: NCT01685827
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Human African Trypanosomiasis (HAT)Sleeping Sickness

Start date: 2012-10-01
Primary completion: 2016-11-11
Enrollment: 394

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.